Responsible for increasing the market penetration of BI products and achieve the sales targets for specific area. Also build relationships and grow BI brand by engaging the opinion leaders in the specified area.
Key account management and hospital management experience is must
Worked in critical care division,cardio and neuro products selling experience is must.
Duties & Responsibilities :
Utilize sales direction and establish effective call patterns to develop and drive sales
targeted hospitals and practitioners to advance the sales cycle.
needs and providing appropriate solutions to advance the sales process.
Pursue with business leaders(high potential doctors) in segmentation targeting
hospital and health care professional level. Execute the plan to accomplish
goals per current sales and marketing direction.
customer records, completing daily call notes and recording of samples. Need to acclimate quickly and use various technology tools
Requirements : (please meneligibility criteria)
Education : Bachelors degree, Masters degree(e.g. MBBS, MSC), Diploma
Major Focus : Pharmacology, Business Admin , Pharmacology
Willingness to travel extensively
Should be able to learn mechanism of action and clinical application concepts easily
Adaptability is critical to quickly respond to changing situations and priorities
Demonstrate strong problem solving and decision making acclimating to various customer needs, interests and processes. Relate to and compare data from different sources.
Commit a course of action based on logical assumptions and factual information
Our Culture :
Boehringer Ingelheim is a research-driven pharmaceutical company and one of the top 20 pharmaceutical firms worldwide. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally in over 100 countries and has more than 47,700 employees.
The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
In 2014, Boehringer Ingelheim achieved net sales of about 13.3 billion euros. R&D expenditure corresponds to 23.1% of its net sales.